Figure 6E shows that exogenously added PGE2 is able to counteract metformin and upregulate all CSC markers tested without affecting the levels of COX2; demonstrating the essentiality of PGE2 in bladder cancer stem cell repopulation. The gene discussed is PTGS2; the disease is urinary bladder cancer.